flufenamic acid has been researched along with dicumarol in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (62.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Buttar, D; Colclough, N; Gerhardt, S; MacFaul, PA; Maskos, K; Phillips, SD; Plowright, A; Steinbacher, S; Steuber, H; Tam, K; Whittamore, P | 1 |
Perrin, JH; Vallner, JJ | 2 |
Chignell, CF; Starkweather, DK | 1 |
Chignell, CF | 1 |
Cepelák, V; Grimová, J; Nĕmecek, O; Roubal, Z | 1 |
Abdelmohsen, K; Daubrawa, F; Klotz, LO; Stuhlmann, D | 1 |
1 review(s) available for flufenamic acid and dicumarol
Article | Year |
---|---|
Drug-protein binding: recent advances in methodology: spectroscopic techniques.
Topics: Camptothecin; Dansyl Compounds; Dicumarol; Drug Interactions; Energy Transfer; Flufenamic Acid; Fluorescence; Humans; Methods; Molecular Conformation; Naphthalenesulfonates; Pharmaceutical Preparations; Protein Binding; Pyrazoles; Serum Albumin; Serum Albumin, Bovine; Spectrometry, Fluorescence; Spectrophotometry; Spectrophotometry, Ultraviolet; Tetracycline; Tryptophan; Warfarin | 1973 |
7 other study(ies) available for flufenamic acid and dicumarol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions.
Topics: Binding Sites; Crystallography, X-Ray; Drug Interactions; Humans; Pharmaceutical Preparations; Protein Binding; Protein Structure, Tertiary; Serum Albumin; Spectrometry, Fluorescence | 2010 |
Preliminary investigations of intrinsic and extrinsic optical activity as purity criterion for human serum albumins.
Topics: Blood Protein Electrophoresis; Circular Dichroism; Dicumarol; Flufenamic Acid; Humans; Hydrogen-Ion Concentration; Phenylbutazone; Protein Binding; Protein Conformation; Quality Control; Serum Albumin; Sodium Dodecyl Sulfate; Spectrophotometry, Ultraviolet; Sulfathiazoles; Ultracentrifugation | 1975 |
Optical studies of drug-protein complexes. V. The interaction of phenylbutazone, flufenamic acid, and dicoumarol with acetylsalicylic acid-treated human serum albumin.
Topics: Acetates; Acylation; Anhydrides; Anti-Inflammatory Agents; Antigens; Aspirin; Binding Sites; Chemical Phenomena; Chemistry; Circular Dichroism; Dialysis; Dicumarol; Drug Tolerance; Flufenamic Acid; Fluorescence; Fluorine; Glycine; Humans; Mathematics; Optical Rotatory Dispersion; ortho-Aminobenzoates; Penicillin G; Phenylbutazone; Protein Binding; Serum Albumin; Sulfonic Acids; Time Factors; Ultraviolet Rays | 1971 |
Effects of nonsteroid anti-inflammatory agents and some dicoumarol derivatives on platelet aggregation, fibrinolysis and stabilization of cell membrane in vitro.
Topics: Anti-Inflammatory Agents; Aspirin; Blood Platelets; Cell Membrane; Chloroquine; Coumarins; Depression, Chemical; Dicumarol; Erythrocytes; Fibrinolysis; Flufenamic Acid; Hemolysis; Humans; Hypotonic Solutions; In Vitro Techniques; Indomethacin; Inflammation; Mefenamic Acid; Oxyphenbutazone; Phenylbutazone; Phenylpropionates; Platelet Adhesiveness; Pyrazoles; Receptors, Drug; Structure-Activity Relationship | 1972 |
Circular dichroic examination of the interaction of some planar acidic drugs with tryptophan-modified human serum albumin.
Topics: Acids; Binding Sites; Chemical Phenomena; Chemistry, Physical; Circular Dichroism; Dicumarol; Flufenamic Acid; Humans; Pharmaceutical Preparations; Phenylbutazone; Protein Binding; Serum Albumin; Sulfathiazoles; Tryptophan | 1981 |
Dicumarol is a potent reversible inhibitor of gap junctional intercellular communication.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Cell Communication; Cell Line; Coloring Agents; Connexin 43; Dicumarol; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Epithelial Cells; Flufenamic Acid; Gap Junctions; Isoquinolines; Liver; Mitogen-Activated Protein Kinase 3; Models, Chemical; Phosphorylation; Rats; Signal Transduction; Time Factors; Uncoupling Agents; Warfarin | 2005 |